Atlas Trials

Evaluation of Efficacy and Safety of Somatostatin Used as Inflow Modulator in Liver Transplantation.

Clinical trial NCT01290172 · COMPLETED

Trial details

NCT number
NCT01290172
Sponsor
University Hospital, Ghent
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Liver Transplant With Clinically Significant Portal Hypertension
Start date
2010-12-01
Primary completion
2013-12-01
Enrollment
33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.